No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.

No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.

Despite the availability of high-sensitive troponin (hs-cTnT), there is still room for improvement in the diagnostic assessment of patients suspected of acute coronary syndrome (ACS). Apart from serial biomarker testing, which is time-consuming, novel biomarkers like copeptin have been proposed to e...

Full description

Bibliographic Details
Main Authors: Judith M Poldervaart, Emma Röttger, Marieke S Dekker, Nicolaas P A Zuithoff, Peter W H M Verheggen, Evelyn A de Vrey, Thierry X Wildbergh, Arnoud W J van 't Hof, Arend Mosterd, Arno W Hoes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4503345?pdf=render

Internet

http://europepmc.org/articles/PMC4503345?pdf=render

Similar Items